Citi, Goldman sell BioMed CMBS as sector slows
Citi and Goldman on Tuesday sold CGGS 2016-RND, a $1.8bn single borrower CMBS transaction backed by one fixed and one floating rate loan made to Blackstone Group to finance its acquisition of BioMed Realty Trust.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: